TY - JOUR
T1 - Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders
T2 - Project mSMART MIND
AU - Minami, Haruka
AU - Brinkman, Hannah R.
AU - Nahvi, Shadi
AU - Arnsten, Julia H.
AU - Rivera-Mindt, Monica
AU - Wetter, David W.
AU - Bloom, Erika Litvin
AU - Price, Lawrence H.
AU - Vieira, Carlos
AU - Donnelly, Remington
AU - McClain, Lauren M.
AU - Kennedy, Katherine A.
AU - D'Aquila, Erica
AU - Fine, Micki
AU - McCarthy, Danielle E.
AU - Graham Thomas, J.
AU - Hecht, Jacki
AU - Brown, Richard A.
N1 - Funding Information:
The project described is supported by Award Number NIDA grant R34 DA037364 from the National Institute on Drug Abuse (PIs: Haruka Minami, Ph.D. and Richard A. Brown, Ph.D.)
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/3
Y1 - 2018/3
N2 - Background: Although individuals with psychiatric disorders are disproportionately affected by cigarette smoking, few outpatient mental health treatment facilities offer smoking cessation services. In this paper, we describe the development of a smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM), as well as the design and methods of an ongoing pilot randomized controlled trial (RCT) targeting smokers receiving outpatient psychiatric treatment. We also report the results of an open-label pilot feasibility study. Methods: In phase 1, we developed and pilot-tested SMI-CM, which includes a smartphone intervention app that prompts participants to practice mindfulness, complete ecological momentary assessment (EMA) reports 5 times per day, and submit carbon monoxide (CO) videos twice per day. Participants earned incentives if submitted videos showed CO ≤ 6 ppm. In phase 2, smokers receiving outpatient treatment for mood disorders are randomized to receive SMI-CM or enhanced standard treatment plus non-contingent CM (EST). Results: The results from the pilot feasibility study (N = 8) showed that participants practiced mindfulness an average of 3.4 times/day (≥ 3 min), completed 72.3% of prompted EMA reports, and submitted 68.0% of requested CO videos. Participants reported that the program was helpful overall (M = 4.85/5) and that daily mindfulness practice was helpful for both managing mood and quitting smoking (Ms = 4.50/5). Conclusions: The results from the feasibility study indicated high levels of acceptability and satisfaction with SMI-CM. The ongoing RCT will allow evaluation of the efficacy and mechanisms of action underlying SMI-CM for improving cessation rates among smokers with mood disorders.
AB - Background: Although individuals with psychiatric disorders are disproportionately affected by cigarette smoking, few outpatient mental health treatment facilities offer smoking cessation services. In this paper, we describe the development of a smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM), as well as the design and methods of an ongoing pilot randomized controlled trial (RCT) targeting smokers receiving outpatient psychiatric treatment. We also report the results of an open-label pilot feasibility study. Methods: In phase 1, we developed and pilot-tested SMI-CM, which includes a smartphone intervention app that prompts participants to practice mindfulness, complete ecological momentary assessment (EMA) reports 5 times per day, and submit carbon monoxide (CO) videos twice per day. Participants earned incentives if submitted videos showed CO ≤ 6 ppm. In phase 2, smokers receiving outpatient treatment for mood disorders are randomized to receive SMI-CM or enhanced standard treatment plus non-contingent CM (EST). Results: The results from the pilot feasibility study (N = 8) showed that participants practiced mindfulness an average of 3.4 times/day (≥ 3 min), completed 72.3% of prompted EMA reports, and submitted 68.0% of requested CO videos. Participants reported that the program was helpful overall (M = 4.85/5) and that daily mindfulness practice was helpful for both managing mood and quitting smoking (Ms = 4.50/5). Conclusions: The results from the feasibility study indicated high levels of acceptability and satisfaction with SMI-CM. The ongoing RCT will allow evaluation of the efficacy and mechanisms of action underlying SMI-CM for improving cessation rates among smokers with mood disorders.
UR - http://www.scopus.com/inward/record.url?scp=85041575549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041575549&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2017.12.014
DO - 10.1016/j.cct.2017.12.014
M3 - Article
C2 - 29288740
AN - SCOPUS:85041575549
SN - 1551-7144
VL - 66
SP - 36
EP - 44
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -